Meta Biomed Co. Ltd Capital Reinvestment Ratio
Meta Biomed Co. Ltd capital reinvestment ratio. Meta Biomed Co. Ltd (059210) has a Capital Reinvestment Ratio of 4.21x as of September 2025, meaning it reinvests 4% of its operating cash flow (₩1.05 Billion) in capital expenditures (₩4.44 Billion). Check Meta Biomed Co. Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Meta Biomed Co. Ltd (2011–2024)
Capital reinvestment ratio of Meta Biomed Co. Ltd from 2011 to 2024. This chart tracks Meta Biomed Co. Ltd's Capital Reinvestment Ratio across 11 annual periods. Also explore Meta Biomed Co. Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Meta Biomed Co. Ltd Capital Reinvestment Ratio by Year (2011–2024)
Meta Biomed Co. Ltd capital reinvestment ratio by year from 2011 to 2024. For the full cash flow conversion analysis, see Meta Biomed Co. Ltd operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.49x | ₩22.63 Billion | ₩11.10 Billion | ▼ -56.4% |
| 2023 | 1.12x | ₩10.22 Billion | ₩11.49 Billion | ▼ -33.1% |
| 2022 | 1.68x | ₩9.16 Billion | ₩15.41 Billion | ▲ +806.2% |
| 2021 | 0.19x | ₩11.14 Billion | ₩2.07 Billion | ▼ -59.5% |
| 2020 | 0.46x | ₩4.86 Billion | ₩2.23 Billion | ▼ -82.6% |
| 2019 | 2.64x | ₩2.86 Billion | ₩7.56 Billion | ▲ +116.8% |
| 2016 | 1.22x | ₩5.03 Billion | ₩6.13 Billion | ▼ -22.9% |
| 2015 | 1.58x | ₩4.93 Billion | ₩7.79 Billion | ▲ +27.5% |
| 2013 | 1.24x | ₩3.71 Billion | ₩4.60 Billion | ▼ -9.7% |
| 2012 | 1.37x | ₩3.83 Billion | ₩5.26 Billion | ▼ -31.5% |
| 2011 | 2.00x | ₩4.10 Billion | ₩8.22 Billion | — |